SUBSCRIBE
SUBSCRIBE
News   Business

Astellas Pharma Inc. Extends Deal to Sell Pfizer Inc.'s Lipitor in Japan

March 29, 2012 | 
1 min read
Pfizer Inc said on Thursday that it has agreed to license Astellas Pharma Inc to make and sell its Lipitor cholesterol drug in Japan to March 2021, extending the term of the previous agreement by five years.
Alliances Asia
Pfizer Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Female handshake. Flat design. Two business women in green and yellow clothes against the blue background of the metropolis shake hands
Leadership
5 Women Biotech Leaders Bagging Billions in M&A Dollars
July 16, 2025
 · 
8 min read
 · 
Tristan Manalac
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Massachusetts-Based Karyopharm, Azurity Cut Workforces
July 14, 2025
 · 
158 min read
 · 
BioSpace Editorial Staff
AbbVie's office in South San Francisco, California
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky